3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
14
Gastrointestinal
9
Gynecologic
5
Thoracic
3
Genitourinary
2
Dermatologic
2
Other
1
Conditions
Prostatic Neoplasms
2
Breast Neoplasms
2
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
Docetaxel
390
pembrolizumab
326
Prednisone
285
Gemcitabine
273
enzalutamide
256
Radiotherapy
251
Nivolumab
248
Magnetic Resonance Spectroscopy
247
Cisplatin
209
Abiraterone Acetate
198
Radiosurgery
184
Leuprolide
182
Sunitinib
169
Carboplatin
161
bicalutamide
148
Goserelin
145
Androgen Antagonists
142
Specimen Handling
138
Ipilimumab
128
Paclitaxel
125
Cyclophosphamide
116
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
110
Bevacizumab
109
Everolimus
107
apalutamide
99
abiraterone
99
cabozantinib
98
atezolizumab
97
Sorafenib
97
Radiation
89
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Motivational Interviewing
×
Genitourinary
×
Clear all
NCT05162846
2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA
Completed
831 enrolled
NCT05354882
2023-05-09
DEFACTO2
Université Sorbonne Paris Nord
Phase NA
Unknown
150 enrolled